Discover How Helix is Changing the World of Healthcare

Resources Hub

Genomics startup Helix receives $33 million in NIH funding to scale COVID-19 testing

News

Jul 31, 2020

Genomics startup Helix receives $33 million in NIH funding to scale COVID-19 testing

TechCrunch

Enhancing Patient Care for Life with Reusable Genetic Information

Podcasts

Jul 23, 2020

Enhancing Patient Care for Life with Reusable Genetic Information

Modeling the Impact of Surveillance Testing on COVID-19 Infection Rates

Blog

Jul 16, 2020

Modeling the Impact of Surveillance Testing on COVID-19 Infection Rates

Helix partners with San Diego County to make COVID-19 testing accessible for those who need it most

Press Releases

Jul 13, 2020

Helix partners with San Diego County to make COVID-19 testing accessible for those who need it most

Blog

Jul 13, 2020

Update on COVID-19 research at Helix

Research

Jul 1, 2020

Modeling the Impact of Surveillance Testing on COVID-19 Infection Rates

Helix

Beyond the cough: symptoms and trends from a COVID-19 survey

Blog

May 26, 2020

Beyond the cough: symptoms and trends from a COVID-19 survey

Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community setting

Research

May 15, 2020

Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community setting

MEDRXIV

Saliva-based COVID-19 testing is less sensitive than nasopharyngeal swabs in the community setting

Blog

May 15, 2020

Saliva-based COVID-19 testing is less sensitive than nasopharyngeal swabs in the community setting

The Latest Content From Helix

Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy

By MD, FACP, FACMG Cassie Hajek, Medical Director at Helix

Recent Press Releases

View All Press Releases

Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

May 28, 2025

Press Releases

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

March 18, 2025

Press Releases

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

March 13, 2025

Recent Published Research

View All Published Research

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

March 19, 2025

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

March 19, 2025

Published Research

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

March 19, 2025

Published Research

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

November 21, 2024

Published Research

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Discover How Helix is Changing the World of Healthcare

Resources Hub

The Latest Content From Helix

Recent Blog Posts

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

MedCity Pivot Podcast: Precision Medicine with the CEO of Helix

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Get in touch

Performance and Applications of Helix Exome+^® Assay